308 related articles for article (PubMed ID: 23314909)
21. S14G-Humanin ameliorates Abeta25-35-induced behavioral deficits by reducing neuroinflammatory responses and apoptosis in mice.
Miao J; Zhang W; Yin R; Liu R; Su C; Lei G; Li Z
Neuropeptides; 2008; 42(5-6):557-67. PubMed ID: 18929410
[TBL] [Abstract][Full Text] [Related]
22. M2 Macrophage Transplantation Ameliorates Cognitive Dysfunction in Amyloid-β-Treated Rats Through Regulation of Microglial Polarization.
Zhu D; Yang N; Liu YY; Zheng J; Ji C; Zuo PP
J Alzheimers Dis; 2016 Mar; 52(2):483-95. PubMed ID: 27003214
[TBL] [Abstract][Full Text] [Related]
23. Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.
Scholtzova H; Chianchiano P; Pan J; Sun Y; Goñi F; Mehta PD; Wisniewski T
Acta Neuropathol Commun; 2014 Sep; 2():101. PubMed ID: 25178404
[TBL] [Abstract][Full Text] [Related]
24. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
[TBL] [Abstract][Full Text] [Related]
25. Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ.
Ittner A; Asih PR; Tan ARP; Prikas E; Bertz J; Stefanoska K; Lin Y; Volkerling AM; Ke YD; Delerue F; Ittner LM
Acta Neuropathol; 2020 Sep; 140(3):279-294. PubMed ID: 32725265
[TBL] [Abstract][Full Text] [Related]
26. Aβ25-35 injection into the temporal cortex induces chronic inflammation that contributes to neurodegeneration and spatial memory impairment in rats.
Diaz A; Limon D; Chávez R; Zenteno E; Guevara J
J Alzheimers Dis; 2012; 30(3):505-22. PubMed ID: 22430532
[TBL] [Abstract][Full Text] [Related]
27. Flavonoids from Stems and Leaves of
Shengkai D; Yazhen S
CNS Neurol Disord Drug Targets; 2022; 21(4):367-374. PubMed ID: 34455972
[TBL] [Abstract][Full Text] [Related]
28. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
[TBL] [Abstract][Full Text] [Related]
29. Preventive Effect of Betaine Against Cognitive Impairments in Amyloid β Peptide-Injected Mice Through Sirtuin1 in Hippocampus.
Ibi D; Kondo S; Ohmi A; Kojima Y; Nakasai G; Takaba R; Hiramatsu M
Neurochem Res; 2022 Aug; 47(8):2333-2344. PubMed ID: 35597887
[TBL] [Abstract][Full Text] [Related]
30. Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice.
Jin G; Wang LH; Ji XF; Chi TY; Qi Y; Jiao Q; Xu Q; Zhou XY; Zhang R; Zou LB
Neurosci Lett; 2014 Jun; 573():58-63. PubMed ID: 24810883
[TBL] [Abstract][Full Text] [Related]
31. Study on Urine Metabolic Profile of Aβ25-35-Induced Alzheimer's Disease Using UHPLC-Q-TOF-MS.
Liu Y; Wei M; Yue K; Hu M; Li S; Men L; Pi Z; Liu Z; Liu Z
Neuroscience; 2018 Dec; 394():30-43. PubMed ID: 30316910
[TBL] [Abstract][Full Text] [Related]
32. Effect of high-fat diet on cognitive impairment in triple-transgenic mice model of Alzheimer's disease.
Sah SK; Lee C; Jang JH; Park GH
Biochem Biophys Res Commun; 2017 Nov; 493(1):731-736. PubMed ID: 28865961
[TBL] [Abstract][Full Text] [Related]
33. Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats.
Cai HY; Hölscher C; Yue XH; Zhang SX; Wang XH; Qiao F; Yang W; Qi JS
Neuroscience; 2014 Sep; 277():6-13. PubMed ID: 24583037
[TBL] [Abstract][Full Text] [Related]
34. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
[TBL] [Abstract][Full Text] [Related]
35. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.
Refolo LM; Malester B; LaFrancois J; Bryant-Thomas T; Wang R; Tint GS; Sambamurti K; Duff K; Pappolla MA
Neurobiol Dis; 2000 Aug; 7(4):321-31. PubMed ID: 10964604
[TBL] [Abstract][Full Text] [Related]
36. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model.
Roberson ED; Scearce-Levie K; Palop JJ; Yan F; Cheng IH; Wu T; Gerstein H; Yu GQ; Mucke L
Science; 2007 May; 316(5825):750-4. PubMed ID: 17478722
[TBL] [Abstract][Full Text] [Related]
37. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
38. Gavage of D-Ribose induces Aβ-like deposits, Tau hyperphosphorylation as well as memory loss and anxiety-like behavior in mice.
Wu B; Wei Y; Wang Y; Su T; Zhou L; Liu Y; He R
Oncotarget; 2015 Oct; 6(33):34128-42. PubMed ID: 26452037
[TBL] [Abstract][Full Text] [Related]
39. Long-Term High-Fat Diet Consumption Aggravates β-Amyloid Deposition and Tau Pathology Accompanied by Microglial Activation in an Alzheimer's Disease Model.
Liang Z; Gong X; Zhao Y; Zhao Y; Yu J; Huang T; Yang C; Wu L; Huang M; Wang X; Shu X; Bao J
Mol Nutr Food Res; 2024 Apr; 68(7):e2300669. PubMed ID: 38491393
[TBL] [Abstract][Full Text] [Related]
40. STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's beta-amyloid deposits.
Cancino GI; Toledo EM; Leal NR; Hernandez DE; Yévenes LF; Inestrosa NC; Alvarez AR
Brain; 2008 Sep; 131(Pt 9):2425-42. PubMed ID: 18559370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
